Literature DB >> 23077864

Inhibition of virus-like particle release of Sendai virus and Nipah virus, but not that of mumps virus, by tetherin/CD317/BST-2.

Weng-Sheng Kong1, Takashi Irie, Asuka Yoshida, Ryoko Kawabata, Takahiro Kadoi, Takemasa Sakaguchi.   

Abstract

Tetherin (also known as BST-2 or CD317) has recently been identified as a potent IFN-induced anti-viral protein that inhibits the release of diverse enveloped virus particles from infected cells. The anti-viral activity of tetherin on a number of enveloped viruses, including retroviruses, filoviruses and arenaviruses, has been examined. Here, we show that tetherin is also capable of blocking the release of virus-like particles (VLPs) driven by the matrix protein of Sendai virus. Together with inhibition of Nipah virus VLP release by tetherin, these results indicate that paramyxoviruses are to be added to the list of viruses that are susceptible to tetherin inhibition. Tetherin co-localized with Nipah virus matrix proteins and accumulated in cells, indicating that it is present at, or recruited to, sites of particle assembly. It should be noted, however, that tetherin was not effective against the release of paramyxovirus mumps VLPs, indicating that certain enveloped viruses may not be sensitive to tetherin activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23077864

Source DB:  PubMed          Journal:  Hiroshima J Med Sci        ISSN: 0018-2052


  12 in total

1.  BST-2/tetherin is overexpressed in mammary gland and tumor tissues in MMTV-induced mammary cancer.

Authors:  Philip H Jones; Wadie D Mahauad-Fernandez; Marisa N Madison; Chioma M Okeoma
Journal:  Virology       Date:  2013-06-25       Impact factor: 3.616

2.  Polymorphisms in Rhesus Macaque Tetherin Are Associated with Differences in Acute Viremia in Simian Immunodeficiency Virus Δnef-Infected Animals.

Authors:  Sanath Kumar Janaka; Aidin Tavakoli-Tameh; William J Neidermyer; Ruth Serra-Moreno; James A Hoxie; Ronald C Desrosiers; R Paul Johnson; Jeffrey D Lifson; Steven M Wolinsky; David T Evans
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

3.  Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat Cells.

Authors:  Markus Hoffmann; Inga Nehlmeier; Constantin Brinkmann; Verena Krähling; Laura Behner; Anna-Sophie Moldenhauer; Nadine Krüger; Julia Nehls; Michael Schindler; Thomas Hoenen; Andrea Maisner; Stephan Becker; Stefan Pöhlmann
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

4.  Tetherin antagonism by V proteins is a common trait among the genus Rubulavirus.

Authors:  Keisuke Ohta; Yusuke Matsumoto; Morihiro Ito; Machiko Nishio
Journal:  Med Microbiol Immunol       Date:  2017-05-02       Impact factor: 3.402

5.  Substitutions in Nef That Uncouple Tetherin and SERINC5 Antagonism Impair Simian Immunodeficiency Virus Replication in Primary Rhesus Macaque Lymphocytes.

Authors:  Sanath Kumar Janaka; Brian J Snow; Ryan T Behrens; David T Evans
Journal:  J Virol       Date:  2022-05-10       Impact factor: 6.549

6.  Early Vertebrate Evolution of the Host Restriction Factor Tetherin.

Authors:  Elena Heusinger; Silvia F Kluge; Frank Kirchhoff; Daniel Sauter
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

Review 7.  Host restriction factors for hepatitis C virus.

Authors:  Li-Ya Zhou; Lei-Liang Zhang
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

8.  Three-Dimensional Structural Characterization of HIV-1 Tethered to Human Cells.

Authors:  Joshua D Strauss; Jason E Hammonds; Hong Yi; Lingmei Ding; Paul Spearman; Elizabeth R Wright
Journal:  J Virol       Date:  2015-11-18       Impact factor: 5.103

Review 9.  Counteraction of the multifunctional restriction factor tetherin.

Authors:  Daniel Sauter
Journal:  Front Microbiol       Date:  2014-04-10       Impact factor: 5.640

10.  CD317 Promotes the survival of cancer cells through apoptosis-inducing factor.

Authors:  Xin Li; Guizhong Zhang; Qian Chen; Yingxue Lin; Junxin Li; Qingguo Ruan; Youhai Chen; Guang Yu; Xiaochun Wan
Journal:  J Exp Clin Cancer Res       Date:  2016-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.